Utidelone capsule alone for advanced solid tumors
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests utidelone capsules as a single treatment for people with certain advanced cancers, including stomach, bile duct, ovarian, esophageal, liver, colorectal, and cervical cancer. It is for those whose cancer has not responded to standard therapy and may offer a new option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these advanced cancers: HER2-negative stomach cancer, bile duct cancer, platinum-resistant ovarian cancer, esophageal cancer, liver cancer, colorectal cancer, or cervical cancer.
- You have received at least one previous standard treatment but no more than four prior treatment lines.
- Your cancer has at least one measurable tumor on a CT or MRI scan.
- You are between 18 and 70 years old and in good enough health to function on your own (ECOG 0-1).
- Your blood counts, liver and kidney function are within certain limits, and you have no active infections or other serious medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral chemotherapy called Utidelone for people with ovarian, fallopian tube, or peritoneal cancer that has stopped responding to platinum-based treatments. It aims to see if this drug can help when standard options have failed or are not tolerated.
This trial tests a new capsule (utidelone) combined with standard chemotherapy as a first treatment for advanced stomach or gastroesophageal junction cancer that cannot be removed by surgery. It aims to see if this combination works better than current options.
This trial tests a combination of two chemotherapy drugs, utidelone and capecitabine, for women with HER2-negative breast cancer that has spread to other parts of the body. The goal is to see if this combination can help shrink tumors and slow the cancer's growth.
This study tests if a new form of the drug Utidelone (given as a capsule) works as well as the current injection for people with HER2-negative advanced breast cancer. It may be an option if you have already had chemotherapy and your cancer is still growing.
This trial tests a combination of two oral drugs (Utidelone and Fruquintinib) for ovarian cancer that has stopped responding to platinum chemotherapy. It may offer a new option when standard treatments stop working.
This trial tests a chemotherapy drug called utidelone given before surgery to shrink high-risk or locally advanced breast cancer. It may help make surgery more effective.
Hear when a new Gastric Cancer Adenocarcinoma Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.